A new therapy prompts immune defense cells to swallow misshapen proteins, amyloid beta plaques and tau tangles, whose buildup is known to kill nearby brain cells as part of Alzheimer’s disease, a new study shows.

Led by researchers at NYU Grossman School of Medicine, the investigation showed that elderly monkeys had up to 59 percent fewer plaque deposits in their brains after treatment with CpG oligodeoxynucleotides (CpG ODN), compared with untreated animals. These amyloid beta plaques are protein fragments that clump together and clog the junctions between nerve cells (neurons).

Brains of treated animals also had a drop in levels of toxic tau. This nerve fiber protein can destroy neighboring tissue when disease-related changes to its chemical structure causes it to catch on other cells.

“Our findings illustrate that this therapy is an effective way of manipulating the immune system to slow neurodegeneration,” says Akash Patel, MS, an assistant research scientist in the Center for Cognitive Neurology at NYU Langone Health.


DAILY DOSE: Trump Replaces Casey Means With Fox News Doctor as Surgeon General Pick; Hidden Piece of Pangaea Revealed Beneath Appalachia.
Trump replaces surgeon general nominee amid vaccine concerns and criticism.
Climate change a global threat to brain health, stroke experts say
Climate change increases stroke risks through extreme weather, with efforts needed to …
Snow cover on Greek mountains has more than halved in four decades, study finds
A study reveals that snow cover in Greece's mountains has decreased by …
UN Women report finds online violence and deepfakes drive women from public life
A report reveals increasing online violence against women, worsening mental health and …

A new therapy prompts immune defense cells to swallow misshapen proteins, amyloid beta plaques and tau tangles, whose buildup is known to kill nearby brain cells as part of Alzheimer’s disease, a new study shows.

Led by researchers at NYU Grossman School of Medicine, the investigation showed that elderly monkeys had up to 59 percent fewer plaque deposits in their brains after treatment with CpG oligodeoxynucleotides (CpG ODN), compared with untreated animals. These amyloid beta plaques are protein fragments that clump together and clog the junctions between nerve cells (neurons).

Brains of treated animals also had a drop in levels of toxic tau. This nerve fiber protein can destroy neighboring tissue when disease-related changes to its chemical structure causes it to catch on other cells.

“Our findings illustrate that this therapy is an effective way of manipulating the immune system to slow neurodegeneration,” says Akash Patel, MS, an assistant research scientist in the Center for Cognitive Neurology at NYU Langone Health.


Processingโ€ฆ
Success! You're on the list.

Leave a Reply

Trending

Discover more from Scientific Inquirer

Subscribe now to keep reading and get access to the full archive.

Continue reading